trial
as of 2026-07-01Event Marker Ingested To Trigger Event Recorder 3.0 Psychiatry Study
NCTId NCT01804257
at a glance
— · Completed
Enrollment 28 (actual)
Sponsored by Proteus Digital Health, Inc.
Primary completion 2011-05
Synthesized from structured facts only — each point cited above.
Design & status
Phase
—
Status
Completed
Enrollment
28 (actual)
Study type
Interventional
Allocation
Na
Model
Single Group
Masking
None
Start
2010-05
Primary completion
2011-05
Eligibility
ALL · 18 Years
Interventions & indications
Sponsors
Proteus Digital Health, Inc.Lead Sponsor
Massachusetts General HospitalCollaborator
The Zucker Hillside HospitalCollaborator
Investigators
1
John M Kane, MDPrincipal Investigator
Sites
2 total
Boston, United StatesGlen Oaks, United States
Facts & assertions
4 sourced
Enrollment
28
Phase
NA
Primary Completion Date
2011-05
Status
COMPLETED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator
person